Aalok Shanghvi
Direttore/Membro del Consiglio presso SUN PHARMACEUTICAL INDUSTRIES LTD.
Patrimonio netto: 64 M $ in data 31/10/2024
Profilo
Aalok Dilip Shanghvi is currently the Executive Director & Head-Business Development at Sun Pharmaceutical Industries Ltd.
He previously worked as a Director at Taro Pharmaceutical Industries Ltd.
and as the Managing Director at Sun Pharmaceutical Industries Ltd.
He completed his undergraduate degree at the University of Michigan.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
15/11/2024 | 2 877 280 ( 0.12% ) | 63 M $ | 31/10/2024 | |
08/11/2024 | 350 162 ( 0.11% ) | 899 286 $ | 31/10/2024 |
Ultime notizie su Aalok Shanghvi
Posizioni attive di Aalok Shanghvi
Società | Posizione | Inizio |
---|---|---|
SUN PHARMACEUTICAL INDUSTRIES LTD. | Direttore/Membro del Consiglio | 01/06/2023 |
Precedenti posizioni note di Aalok Shanghvi
Società | Posizione | Fine |
---|---|---|
TARO PHARMACEUTICAL INDUSTRIES LTD. | Direttore/Membro del Consiglio | 18/07/2013 |
SUN PHARMACEUTICAL INDUSTRIES LTD. | Amministratore Delegato | - |
Formazione di Aalok Shanghvi
University of Michigan | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SUN PHARMACEUTICAL INDUSTRIES LTD. | Health Technology |
Aziende private | 1 |
---|---|
Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd. Pharmaceuticals: MajorHealth Technology Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel. | Health Technology |
- Borsa valori
- Insiders
- Aalok Shanghvi